Table 3. Clinical characteristics of the study population according to the recurrence of cardiac events .
| Cardiac events | Yes (n = 32) | No (n = 138) |
| Males [n (%)] | 29 (90.62) | 133 (96.38) |
| Age (years) | 34.56 ± 4.59 | 34.51 ± 4.90 |
| Persistent smokers [n (%)] | 21 (65.62)* | 43 (31.16) |
| Hypertension [n (%)] | 11 (34.38) | 45 (32.61) |
| Blood pressure < 140/90 mmHg during the follow-up [n (%)] | 28 (87.50)* | 120 (86.95) |
| Hyperlipemia [n (%)] | 11 (34.38) | 32 (23.19) |
| LDL < 100 mg/dl during the follow-up [n (%)] | 26 (81.25) | 115 (83.33) |
| Diabetes mellitus [n (%)] | 5 (15.63) | 8 (5.79) |
| Glycated hemoglobin < 6% during the follow-up [n (%)] | 31 (96.88) | 135 (97.83) |
| Family history [n (%)] | 4 (12.50) | 15 (10.87) |
| Antiplatelet treatment [n (%)] | 32 (100) | 138 (100) |
| Statin [n (%)] | 32 (100) | 130 (94.20) |
| β-blockers [n (%)] | 30 (93.75) | 132 (95.65) |
| ACEI/ARB [n (%)] | 28 (87.50) | 116 (84.06) |
* Different from event-free group at p < 0.05.
ACEI/ARB, angiotensin converting enzyme inhibitor/angiotensin receptor blocker; LDL-C, low-density lipoprotein cholesterol.